Ulipristal Acetate Improves Clinical Symptoms in Women with Adenomyosis and Uterine Myomas

Meritxell Gràcia; Meritxell Gracia; Marta Alcalà; Janisse Ferreri; Mariona Rius; Cristina Ros; Adela Saco; María Adela Saco; María Ángeles Martínez-Zamora; Maria Ángeles Martínez‐Zamora; Francisco Carmona

doi:10.1016/j.jmig.2018.04.002

Ulipristal Acetate Improves Clinical Symptoms in Women with Adenomyosis and Uterine Myomas

Meritxell Gràcia, Meritxell Gracia, Marta Alcalà, Janisse Ferreri, Mariona Rius, Cristina Ros, Adela Saco, María Adela Saco, María Ángeles Martínez-Zamora, Maria Ángeles Martínez‐Zamora, Francisco Carmona

Journal of minimally invasive gynecology · 2018 · vol. 25(7) , pp. 1274–1280 · doi:10.1016/j.jmig.2018.04.002 · PMID:29626678 · W2795713144

article OA: closed CC0 ⤵ 19 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Ulipristal acetate was investigated and found to improve clinical symptoms in women diagnosed with adenomyosis and uterine myomas.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

adenomyosis

MeSH descriptors

Adenomyosis Contraceptive Agents, Female Leiomyoma Norpregnadienes Uterine Neoplasms Adenomyosis Adenomyosis Adult Contraceptive Agents, Female Female Humans Leiomyoma Leiomyoma Middle Aged Norpregnadienes Retrospective Studies Treatment Outcome Uterine Neoplasms Uterine Neoplasms

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (26)

Adenomyosis demonstrates increased expression of the basic fibroblast growth factor receptor/ligand system compared with autologous endometrium via openalex
Adenomyosis: Review of the Literature via openalex
A new concept of endometriosis and adenomyosis: tissue injury and repair (TIAR) via openalex
Clinical utility of progesterone receptor modulators and their effect on the endometrium via openalex
FIGO classification system (PALM‐COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age via openalex
Imaging for Uterine Myomas and Adenomyosis via openalex
Limitations of transvaginal sonography for the diagnosis of adenomyosis, with histopathological correlation via openalex
Progesterone receptor modulators for endometriosis via openalex
Systematic review of endometriosis pain assessment: how to choose a scale? via openalex
Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group via openalex
Transvaginal Ultrasound for the Diagnosis of Adenomyosis: Systematic Review and Meta-Analysis via openalex
Transvaginal ultrasound or MRI for diagnosis of adenomyosis via openalex
Understanding adenomyosis: a case control study via openalex
W2036114582 via openalex
W2033363713 via openalex
W2098707038 via openalex
W2022534203 via openalex
W2106587450 via openalex
W2119515611 via openalex
W2014463766 via openalex
W1996284739 via openalex
W2571094788 via openalex
W1996100965 via openalex
W6649372403 via openalex
W2075217182 via openalex
W6741581601 via openalex

Cited by (19)

Source provenance

europepmc: last seen: 2026-06-04T01:30:01.192114+00:00
openalex: last seen: 2026-06-04T00:00:01.174412+00:00
pubmed: last seen: 2026-05-13T22:19:49.066213+00:00

License: CC0 · commercial use OK

[1] Adenomyosis demonstrates increased expression of the basic fibroblast growth factor receptor/ligand system compared with autologous endometrium via openalex

[2] Adenomyosis: Review of the Literature via openalex

[3] A new concept of endometriosis and adenomyosis: tissue injury and repair (TIAR) via openalex

[4] Clinical utility of progesterone receptor modulators and their effect on the endometrium via openalex

[5] FIGO classification system (PALM‐COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age via openalex

[6] Imaging for Uterine Myomas and Adenomyosis via openalex

[7] Limitations of transvaginal sonography for the diagnosis of adenomyosis, with histopathological correlation via openalex

[8] Progesterone receptor modulators for endometriosis via openalex

[9] Systematic review of endometriosis pain assessment: how to choose a scale? via openalex

[10] Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group via openalex

[11] Transvaginal Ultrasound for the Diagnosis of Adenomyosis: Systematic Review and Meta-Analysis via openalex

[12] Transvaginal ultrasound or MRI for diagnosis of adenomyosis via openalex

[13] Understanding adenomyosis: a case control study via openalex

[14] W2036114582 via openalex

[15] W2033363713 via openalex

[16] W2098707038 via openalex

[17] W2022534203 via openalex

[18] W2106587450 via openalex

[19] W2119515611 via openalex

[20] W2014463766 via openalex

[21] W1996284739 via openalex

[22] W2571094788 via openalex

[23] W1996100965 via openalex

[24] W6649372403 via openalex

[25] W2075217182 via openalex

[26] W6741581601 via openalex